MEDIPOST Co., Ltd. (KOSDAQ:078160)
13,590
-90 (-0.66%)
Sep 18, 2025, 3:30 PM KST
MEDIPOST Market Cap
MEDIPOST has a market cap or net worth of 466.47 billion as of September 17, 2025. Its market cap has increased by 121.36% in one year.
Market Cap
466.47B
Enterprise Value
493.05B
Revenue
72.17B
Ranking
n/a
PE Ratio
n/a
Stock Price
13,590.00
Market Cap Chart
Since July 29, 2005, MEDIPOST's market cap has increased from 189.41B to 466.47B, an increase of 146.28%. That is a compound annual growth rate of 4.57%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 17, 2025 | 466.47B | 18.75% |
Dec 30, 2024 | 392.82B | 41.18% |
Dec 28, 2023 | 278.25B | 15.66% |
Dec 29, 2022 | 240.56B | -30.37% |
Dec 30, 2021 | 345.51B | -35.57% |
Dec 30, 2020 | 536.26B | -1.14% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Samsung Biologics | 73.74T |
Celltrion | 37.16T |
ALTEOGEN | 26.35T |
Yuhan | 8,924.87B |
SK Biopharmaceuticals | 8,669.28B |
Peptron | 6,977.56B |
PharmaResearch | 6,524.70B |
ABL Bio | 5,528.46B |